Strongyloidiasis risk factors: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 15: | Line 15: | ||
*[[Tuberculosis]] | *[[Tuberculosis]] | ||
*[[Malnutrition]] | *[[Malnutrition]] | ||
*[[Diabetes mellitus]], [[chronic obstructive pulmonary disease (COPD | *[[Diabetes mellitus]], [[chronic obstructive pulmonary disease]] ([[COPD]]), [[renal failure|chronic renal failure]]. | ||
*People living in endemic regions. | *People living in endemic regions. | ||
*[[Alcoholics]] | *[[Alcoholism|Alcoholics]] | ||
* | *Travelers, immigrants | ||
==References== | ==References== | ||
Revision as of 16:04, 9 August 2017
|
Strongyloidiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Strongyloidiasis risk factors On the Web |
|
American Roentgen Ray Society Images of Strongyloidiasis risk factors |
|
Risk calculators and risk factors for Strongyloidiasis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common risk factors in the development of strongyloidiasis include immunosuppressive therapies with corticosteroids and other medications, HTLV-1 infection, organ transplantation, immune reconstitution syndrome, hematologic malignancies (especially lymphoma), tuberculosis, and malnutrition.
Risk factors
Common risk factors in the development of strongyloidiasis include: [1][2]
- Occupations that increase contact with contaminated soil such as farming and coal mining
- human T-cell lymphotropic virus-1 (HTLV-1) infection
- Immunosuppressive therapy with corticosteroids and other medications,
- Immune reconstitution syndrome
- Hematologic malignancies (lymphoma)
- Tuberculosis
- Malnutrition
- Diabetes mellitus, chronic obstructive pulmonary disease (COPD), chronic renal failure.
- People living in endemic regions.
- Alcoholics
- Travelers, immigrants
References
- ↑ Evering T, Weiss LM (2006). "The immunology of parasite infections in immunocompromised hosts". Parasite Immunol. 28 (11): 549–65. doi:10.1111/j.1365-3024.2006.00886.x. PMC 3109637. PMID 17042927.
- ↑ Ostera G, Blum J (2016). "Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States". Curr Trop Med Rep. 3: 1–3. doi:10.1007/s40475-016-0065-3. PMC 4757600. PMID 26925367.